Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without compromising the safety of patients. A new large-scale study co-led by UCLA ...

"This study offers a new way of thinking about prostate cancer risk assessment," said Boutros, who also serves as the interim vice dean for research at the David Geffen School of Medicine at UCLA ...